---
title: "Rexulti (brexpiprazole), all indications: Access and coverage questions"
description: "Access and coverage questions on Rexulti (brexpiprazole) that apply to every indication, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Access and billing. Questions: What are the NDC numbers for Rexulti? 1 question quoted from 1 source."
canonical: "https://www.evicenter.com/medical-information/rexulti/access-and-coverage"
published: "2026-11-14T01:54:55-05:00"
modified: "2026-11-14T01:54:55-05:00"
---

# Rexulti (brexpiprazole), all indications: Access and coverage questions

Manufacturer: Otsuka America Pharmaceutical, Inc.; Lundbeck  
Prescribing information: [Rexulti](https://www.otsuka-us.com/media/static/Rexulti-PI.pdf)  
Indication pages: [Major depressive disorder](https://www.evicenter.com/medical-information/rexulti--major-depressive-disorder)

## Access and billing

<a id="rexulti-ndc"></a>

### What are the NDC numbers for Rexulti?

> “REXULTI (brexpiprazole) tablets have markings on one side and are available in the following strengths and 
> package configurations (see below): 
> • 
> 0.25 mg tablets are light brown, round, shallow convex, bevel-edged body with “BRX” and “0.25” 
> imprinted on one side 
> NDC 59148-035-13 
> Bottles of 30  
> • 
> 0.5 mg tablets: are light orange, round, shallow convex, bevel-edged body with “BRX” and “0.5” 
> imprinted on one side 
> NDC 59148-036-13 
> Bottles of 30  
> • 
> 1 mg tablets are light yellow, round, shallow convex, bevel-edged body with “BRX” and “1” imprinted on 
> one side 
> NDC 59148-037-13 
> Bottles of 30  
> • 
> 2 mg tablets are light green, round, shallow convex, bevel-edged body with “BRX” and “2” imprinted on 
> one side 
> NDC 59148-038-13 
> Bottles of 30  
> • 
> 3 mg tablets are light purple, round, shallow convex, bevel-edged body with “BRX” and “3” imprinted on 
> one side 
> NDC 59148-039-13 
> Bottles of 30  
> • 
> 4 mg tablets are white, round, shallow convex, bevel-edged body with “BRX” and “4” imprinted on one 
> side 
> NDC 59148-040-13 
> Bottles of 30”

Source: [REXULTI: Prescribing information, page 38, captured 2026-11-13](https://www.otsuka-us.com/media/static/Rexulti-PI.pdf#page=38)

## Related pages
- [Medical information: Rexulti (brexpiprazole): All indications](https://www.evicenter.com/medical-information/rexulti)
- [Indication](https://www.evicenter.com/medical-information/rexulti/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/rexulti/pharmacology)
- [Safety](https://www.evicenter.com/medical-information/rexulti/safety)
- [Specific populations](https://www.evicenter.com/medical-information/rexulti/specific-populations)
- [Drug interactions](https://www.evicenter.com/medical-information/rexulti/drug-interactions)
- [Dosing and administration](https://www.evicenter.com/medical-information/rexulti/dosing-and-administration)
- [Storage and supply](https://www.evicenter.com/medical-information/rexulti/storage-and-supply)
